Pantoprazol Stada (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Stada, is a proton pump inhibitor presented as a unknown strength/oral form for oral use. It treats acid‑related disorders such as GERD, ulcers and Zollinger‑Ellison syndrome in adult patients. GNH USA supplies Pantoprazol Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Stada is a proton pump inhibitor that reduces gastric acid secretion in several acid‑related conditions. - Gastro‑esophageal reflux disease (GERD): relieves heartburn and promotes healing of the esophageal lining. - Erosive esophagitis: supports regeneration of damaged esophageal tissue. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumors. - Peptic ulcer disease: aids the healing of gastric and duodenal ulcers.

Pantoprazol Stada may cause adverse reactions, most of which are mild and self‑limiting.

Common Side Effects: - Headache - Diarrhea - Nausea - Abdominal pain - Flatulence - Constipation

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Clostridioides difficile‑associated colitis - Low magnesium levels (hypomagnesemia) - Acute interstitial nephritis - Liver enzyme abnormalities - Stevens‑Johnson syndrome

Before the use of Pant  un un un un ... ... ... ... ... ... ...  ....